Angion Biomedica
Uniondale, US · Delaware corporation
Founders & leadership
ID
Itzhak D. GoldbergFounder
Board
MY
Michael YaminBoard director
Reported raises · per SEC filings
Form D private placements$52M disclosed across 8 rounds · 2015–2024
▶$6MraisedMar 2024 · 1 investors · BiotechnologyRule 506(b)
▶$6MraisedMar 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Yekaterina ChudnovskyDirector
- Karen WilsonDirector
- Christopher HaqqExecutive Officer
- Jay VenkatesanDirector
- Carol AsheDirector
- Brian PiekosExecutive Officer
- Robert ConnellyExecutive Officer, Director
- Allen NissensonDirector
- Robert RuffoloDirector
- Peter DeMuthExecutive Officer
- Julian AdamsDirector
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedJan 2024 · 1 investors · BiotechnologyRule 506(b)
▶$7MraisedJan 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert RuffoloDirector
- Yekaterina ChudnovskyDirector
- Carol AsheDirector
- Peter DeMuthExecutive Officer
- Christopher HaqqExecutive Officer
- Jay VenkatesanDirector
- Robert ConnellyDirector, Executive Officer
- Brian PiekosExecutive Officer
- Karen WilsonDirector
- Allen NissensonDirector
- Julian AdamsDirector
- Offering amount
- $7M
- Amount sold
- $7M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.7MraisedJun 2020 · 54 investors · BiotechnologyRule 506(b)
▶$6.7MraisedJun 2020 · 54 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Allen NissensonDirector
- Jay R. VenkatesanExecutive Officer, Director
- Karen WilsonDirector
- Itzhak D. GoldbergExecutive Officer, Director
- Victor GanziDirector
- Gil OmennDirector
- Offering amount
- $40M
- Amount sold
- $6.7M
- Minimum investment
- $25K
- Sales commissions
- $4M
- Placement agents
- GP Nurmenkari Inc., T.R. Winston & Company, LLC
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedJan 2020 · 7 investors · BiotechnologyRule 506(b)
▶$1MraisedJan 2020 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jay R. VenkatesanExecutive Officer, Director
- Victor GanziDirector
- Itzhak D. GoldbergExecutive Officer, Director
- Michael YaminDirector
- Offering amount
- $12M
- Amount sold
- $1M
- Minimum investment
- $65K
- Sales commissions
- $1.2M
- Placement agents
- GP Nurmenkari Inc., T.R. Winston & Company, LLC
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.1MraisedJan 2020 · 51 investors · BiotechnologyRule 506(b)
▶$6.1MraisedJan 2020 · 51 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Victor GanziDirector
- Michael YaminDirector
- Jay R. VenkatesanExecutive Officer, Director
- Itzhak D. GoldbergExecutive Officer, Director
- Offering amount
- $12M
- Amount sold
- $6.1M
- Minimum investment
- $10K
- Sales commissions
- $563.2K
- Placement agents
- GP Nurmenkari Inc., T.R. Winston & Company, LLC
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.4MraisedJul 2018 · 133 investors · BiotechnologyRule 506(b)
▶$15.4MraisedJul 2018 · 133 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Itzhak D. GoldbergExecutive Officer, Director
- Jay VenkatesanExecutive Officer, Director
- Michael YaminDirector
- Offering amount
- $35M
- Amount sold
- $15.4M
- Minimum investment
- $15K
- Sales commissions
- $3M
- Placement agents
- GP Nurmenkari Inc., T.R. Winston & Company, LLC, H.C. Wainright & Co., LLC
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.4MraisedJul 2018 · 18 investors · BiotechnologyRule 506(b)
▶$5.4MraisedJul 2018 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jay VenkatesanExecutive Officer, Director
- Itzhak D. GoldbergExecutive Officer, Director
- Michael YaminDirector
- Offering amount
- $5.4M
- Amount sold
- $5.4M
- Minimum investment
- $50.1K
- Sales commissions
- $363.2K
- Placement agents
- T.R. Winston & Company, LLC
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.4MraisedFeb 2015 · 23 investors · BiotechnologyRule 506(b)
▶$4.4MraisedFeb 2015 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael YaminDirector
- Itzhak D. GoldbergExecutive Officer, Director
- Offering amount
- $15M
- Amount sold
- $4.4M
- Minimum investment
- $15.6K
- Sales commissions
- $296.5K
- Placement agents
- T.R. Winston & Company, LLC
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Angion Biomedica?
- Angion Biomedica was founded by Itzhak D. Goldberg.
- How much funding has Angion Biomedica raised?
- Angion Biomedica has disclosed $52M raised across 8 rounds.
- Where is Angion Biomedica headquartered?
- Angion Biomedica is headquartered in Uniondale, US.